Building a Business > Regional initiatives > archive

Realizing potential: the state of Asian bioentrepreneurship
April 2003
An overview of biotechnology entrepreneurship activities in the Asia-Pacific region, where the industry is colorful and diverse, and the development potential is enormous.

Success from a virtual structure
May 1999
A virtual organization coordinating the resources of 170 companies and research institutes is providing a dramatic push forward for German biotechnology.

Not enough biotechs, and what government can do about it
May 1999
While financial markets may believe there are too many biotechnology companies in the world, research suggests that the opposite is true.

Financing biotech ventures in Scandinavia
May 1999
Scandinavia's Medicon Valley is experiencing a spurt of funding, prompted by a combination of government and private capital.

Is consolidation the only option for UK biotech?
May 1999
Yes, if it is to have the resources needed to develop products of interest to large pharmaceutical partners.

Can your company benefit from German financing?
May 1999
There are many ways to access German money, but the decision must be based on sound strategy rather than a dire need.

Promoting an activist role for venture capitalists in Germany
May 1999
A growing biotechnology industry depends on venture capital for more than money.

Venture capital with a European twist
May 1999
Cultural factors suggest that European venture capitalists will follow a different model than their US counterparts in selecting companies to fund.

Economic trends in European venture capital
May 1999
Government initiatives, growth of small-cap markets, and a change in investor attitudes has promoted an increase in European venture funding.

The European university as a startup generator
February 1999
Universities continue to foster new company formation in Europe's limited venture capital system.

Cementing links between industry and the university
May 1998
University research is driven not by market–led considerations, but by the search for new knowledge. In this light, how can academic–industry alliances be fostered effectively?